Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Design of Adverse Drug Events-Scorecards
View through CrossRef
This paper presents the design of Adverse Drug Event-Scorecards. The scorecards described are innovative and novel, not having previously been reported in the literature. The Scorecards provide organizations (e.g. hospitals) with summary information about Adverse Drug Events (ADEs) using a Web-based platform. The data used in the Scorecards are routinely updated and report on ADEs detected through data mining processes. The development of the ADE Scorecards is ongoing and they are currently undergoing clinical testing.
Title: Design of Adverse Drug Events-Scorecards
Description:
This paper presents the design of Adverse Drug Event-Scorecards.
The scorecards described are innovative and novel, not having previously been reported in the literature.
The Scorecards provide organizations (e.
g.
hospitals) with summary information about Adverse Drug Events (ADEs) using a Web-based platform.
The data used in the Scorecards are routinely updated and report on ADEs detected through data mining processes.
The development of the ADE Scorecards is ongoing and they are currently undergoing clinical testing.
Related Results
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
OBJECTIVES. The purposes of this study were to develop a pediatric-focused tool for adverse drug event detection and describe the incidence and characteristics of adverse drug even...
Awareness of Adverse Drug Reactions and its Reporting among Third-year Undergraduate Medical Students
Awareness of Adverse Drug Reactions and its Reporting among Third-year Undergraduate Medical Students
Background: Drug is a double-edged sword. Though important, Adverse Drug Reactions under-reporting is real and is mainly due to lack of awareness. No published research has ever ev...
Expert Perceptions on Vaccines in Nigeria
Expert Perceptions on Vaccines in Nigeria
This set of scorecards presents a comparative assessment of the Research and Development (R&D) ecosystems for Regenerative Agriculture (RA) and Human Vaccines across Ghana, Nig...
Expert Perceptions on Regenerative Agriculture in Ghana
Expert Perceptions on Regenerative Agriculture in Ghana
This set of scorecards presents a comparative assessment of the Research and Development (R&D) ecosystems for Regenerative Agriculture (RA) and Human Vaccines across Ghana, Nig...